Roche · 15 hours ago
2026 Summer Intern - DDC
South San Francisco
Internship
Hybrid
Intern
$50/hr - $50/hr
Start in 2026 SpringRoche is a leading biotechnology company, and they are seeking a 2026 Summer Intern for their AI Enablement team within the Computational Sciences Center of Excellence. The intern will work on building large scale training repositories for foundational models, extending training to use multimodal data, and presenting their work at ML Conferences.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Build large scale training repository for foundational models
Extend the DINO/CLIP training to use multimodal data
Write evaluation scripts on various internal benchmark datasets
Present and publish your work to at ML Conferences
Qualification
Required
Must be pursuing a Master's Degree (enrolled student)
Must have attained a Master's Degree
Must be pursuing a PhD (enrolled student)
Must have attained a PhD
Computer Science
Python programming with familiarity of PyTorch and Transformers library
Understanding of Machine Learning and basics of Deep Learning
Model training, fine-tuning (LoRA), and hyper-parameter tunning
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Ability to write technical report / research paper
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
Founded in 1896
10001+ employees
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Alan Hippe
Member of the Executive Board - Group CFO
Christine Bakan
Global Head and VP of Software and Bioinformatics, Next Generation Sequencing
Recent News
Pharmaceutical Technology
2026-01-13
2026-01-12
Company data provided by crunchbase